Overview
Ataxia-oculomotor apraxia type 4 (AOA4) is a very rare inherited neurological condition that affects the brain and nervous system. It belongs to a group of disorders called ataxia-oculomotor apraxias, which share two main features: progressive difficulty with coordination and balance (ataxia) and trouble moving the eyes voluntarily to look at things (oculomotor apraxia). AOA4 is caused by mutations in the PNKP gene, which plays an important role in repairing damaged DNA in our cells. When this gene does not work properly, nerve cells in the brain — especially in the cerebellum, the part that controls balance and coordination — gradually break down over time. People with AOA4 typically begin showing symptoms in childhood or adolescence. Early signs often include unsteady walking, frequent stumbling, and difficulty with eye movements. Over time, the condition tends to worsen, and individuals may develop additional neurological problems such as peripheral neuropathy (damage to nerves in the hands and feet causing numbness or weakness), dystonia (involuntary muscle contractions), and sometimes cognitive difficulties. Some patients may also have elevated levels of certain proteins in their blood, such as alpha-fetoprotein or albumin, which can help with diagnosis. Currently, there is no cure for AOA4. Treatment focuses on managing symptoms and maintaining quality of life. Physical therapy, occupational therapy, and speech therapy can help patients maintain function for as long as possible. Research into DNA repair disorders is ongoing, and understanding of this condition continues to grow.
Also known as:
Key symptoms:
Progressive difficulty with balance and coordination (ataxia)Trouble moving the eyes voluntarily (oculomotor apraxia)Unsteady or wobbly walkingNumbness or tingling in hands and feet (peripheral neuropathy)Muscle weakness in the limbsInvoluntary muscle contractions or abnormal postures (dystonia)Slurred or slow speechDifficulty with fine motor tasks like writing or buttoning clothesReduced reflexesPossible mild cognitive difficultiesElevated blood levels of alpha-fetoproteinCerebellar atrophy visible on brain MRI
Clinical phenotype terms (21)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Ataxia-oculomotor apraxia type 4.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Ataxia-oculomotor apraxia type 4 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Ataxia-oculomotor apraxia type 4.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Ataxia-oculomotor apraxia type 4.
Community
No community posts yet. Be the first to share your experience with Ataxia-oculomotor apraxia type 4.
Start the conversation →Latest news about Ataxia-oculomotor apraxia type 4
No recent news articles for Ataxia-oculomotor apraxia type 4.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How quickly is this condition likely to progress in my child's case?,What therapies should we start right away to maintain function?,Are there any clinical trials or research studies we could participate in?,What signs should we watch for that would indicate the disease is getting worse?,Should other family members be tested for carrier status?,What school or workplace accommodations would you recommend?,How often should we schedule follow-up visits and brain imaging?
Common questions about Ataxia-oculomotor apraxia type 4
What is Ataxia-oculomotor apraxia type 4?
Ataxia-oculomotor apraxia type 4 (AOA4) is a very rare inherited neurological condition that affects the brain and nervous system. It belongs to a group of disorders called ataxia-oculomotor apraxias, which share two main features: progressive difficulty with coordination and balance (ataxia) and trouble moving the eyes voluntarily to look at things (oculomotor apraxia). AOA4 is caused by mutations in the PNKP gene, which plays an important role in repairing damaged DNA in our cells. When this gene does not work properly, nerve cells in the brain — especially in the cerebellum, the part that c
How is Ataxia-oculomotor apraxia type 4 inherited?
Ataxia-oculomotor apraxia type 4 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Ataxia-oculomotor apraxia type 4 typically begin?
Typical onset of Ataxia-oculomotor apraxia type 4 is childhood. Age of onset can vary across affected individuals.